Voloridge Investment Management
AMED

Voloridge Investment Management’s Amedisys AMED Stock Holding History

Voloridge Investment Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-39,149
Closed -$3.85M – 1164
2025
Q2 		$3.85M Buy
39,149
+30,305
+343% +$2.87M 0.01% 821
2025
Q1 		$819K Buy
+8,844
New +$815K ﹤0.01% 1068
2023
Q4 		– Sell
-108,156
Closed -$10.1M – 1140
2023
Q3 		$10.1M Sell
108,156
-65,594
-38% -$6.06M 0.05% 459
2023
Q2 		$15.9M Buy
173,750
+54,821
+46% +$4.5M 0.08% 349
2023
Q1 		$8.75M Sell
118,929
-70,593
-37% -$6.11M 0.04% 488
2022
Q4 		$15.8M Buy
189,522
+111,210
+142% +$10M 0.09% 313
2022
Q3 		$7.58M Buy
78,312
+8,374
+12% +$999K 0.04% 526
2022
Q2 		$7.35M Sell
69,938
-16,251
-19% -$2.08M 0.04% 545
2022
Q1 		$14.8M Sell
86,189
-51,361
-37% -$7.67M 0.08% 312
2021
Q4 		$22.3M Sell
137,550
-18,872
-12% -$3.03M 0.12% 236
2021
Q3 		$23.3M Buy
156,422
+133,750
+590% +$27.8M 0.15% 167
2021
Q2 		$5.55M Buy
22,672
+21,389
+1,667% +$5.61M 0.04% 602
2021
Q1 		$340K Sell
1,283
-199
-13% -$56.1K ﹤0.01% 1245
2020
Q4 		$435K Sell
1,482
-3,744
-72% -$960K ﹤0.01% 1149
2020
Q3 		$1.24M Buy
+5,226
New +$1.19M 0.01% 867
2020
Q2 		– Sell
-10,630
Closed -$1.95M – 1234
2020
Q1 		$1.95M Sell
10,630
-24,847
-70% -$4.42M 0.06% 347
2019
Q4 		$5.92M Buy
+35,477
New +$5.28M 0.12% 228
2019
Q2 		– Sell
-19,809
Closed -$2.44M – 738
2019
Q1 		$2.44M Buy
+19,809
New +$2.49M 0.07% 254
2018
Q4 		– Sell
-35,265
Closed -$4.41M – 402
2018
Q3 		$4.41M Buy
+35,265
New +$3.89M 0.1% 154

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Voloridge Investment Management's AMED Position: Q3 2025 in Review

Voloridge Investment Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 39,149 shares — an estimated $3.85M sold.

Voloridge Investment Management first reported a position in AMED in Q3 2018 and held it in 19 quarters. The position peaked at $23.3M in Q3 2021. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Voloridge Investment Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Voloridge Investment Management sold 39,149 Amedisys shares in Q3 2025, an estimated $3.85M.
  • Voloridge Investment Management first reported a position in Amedisys in Q3 2018 and held it in 19 quarters.
  • Voloridge Investment Management's Amedisys position peaked at $23.3M in Q3 2021.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Voloridge Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.